Bharat Biotech over Covaxin deal row: No payment received from Brazil govt, ‘step-by-step’ approach followed
"As of 29th June 2021, Bharat Biotech has not received any advance payments nor supplied any vaccines to Ministry of…
"As of 29th June 2021, Bharat Biotech has not received any advance payments nor supplied any vaccines to Ministry of…
The conclusion was reached on the basis of two studies conducted on the blood serum of people who were vaccinated…
Speaking at a press conference, Marcelo informed that in its preliminary analysis, the CGU did not find any wrongdoing in…
The Union government’s affidavit in the Supreme Court on the availability of vaccines exhibits that Bharat Biotech will have to…
An important question being investigated is the reason why Bolsonaro's government made a quick vaccine deal with Bharat Biotech when…
On Thursday, Brazil’s President Jair Bolsonaro affirmed that the country never paid or received any doses of COVID 19 vaccine…
A Subject Expert Committee (SEC) under the drugs regulator is likely to meet today to evaluate and discuss the results…
Covaxin has inched a step closer to WHO emergency use listing. The pre-submission meeting with WHO is now planned for…
The Hyderabad-based company said that it should be allowed to maintain a differential pricing strategy for the government hospitals and…
The crucial phase 3 trial data of Bharat Biotech’s Covaxin, detailing the efficacy of the indigenous COVID-19 vaccine produced by…
Bharat Biotech’s Covaxin has been denied by the FDA for emergency use in the United States of America. The US…
The FDA's rejection of an interim approval will delay Bharat Biotech's plan to export its vaccine to the United States.